Home / Tenofovir Disoproxil / Canada
CA ATC J05AF07 · updated 2 Nov 2026
Tenofovir Disoproxil shortage in Canada
Is there a Tenofovir Disoproxil shortage in Canada?
Yes. As of 2 Nov 2026, 2 Tenofovir Disoproxil products are reported short in Canada, the first since 5 May 2025. The company estimate for the return is 12 Jan 2027. Main reason: manufacturing problem.
Also short in Spain, Austria, Belgium, Czechia, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MYLAN-TENOFOVIR DISOPROXIL (30BT) | MYLAN PHARMACEUTICALS ULC | 5 May 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | PMS-TENOFOVIR (30) | PHARMASCIENCE INC | 16 Sep 2026 | 12 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.